retatrutide mash just delivered the first top-line Phase 3 results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Reta 30 – Retatrutide Pen

Vascular and Gastrointestinal Research Due to its origin from gastric juice compounds

This dual-action approach improves skin texture, firmness, and elasticity over time

Kidney Protection Type 2 diabetes is the leading cause of kidney failure

Restraint Supply shortages and compounding restrictions Australia is facing widespread shortages of GLP-1 receptor agonists such as semaglutide (Ozempic) and dulaglutide (Trulicity), since late 2022 and has been a major issue which is due to growing demand surpassing production, further affecting type 2 diabetes care, cardiovascular risk reduction and weight management in patients

Medical contraindications and safety There are situations where GLP-1 or GLP-1/GIP medicines are not appropriate, such as during pregnancy or breastfeeding

Peptide Reconstitution & Concentration Calculator Accurate research peptide concentration, reconstitution and dilution calculations for lyophilised peptides